Derivative Works. (i) The Company may create Company Related Enhancements from the Licensed Intellectual Property, subject to the terms of the License Grant. (ii) Except as may be imposed by other provisions of this Agreement, such as confidentiality and non-compete provisions, no restrictions are imposed on the Company’s rights to create Independent Developments.
Appears in 7 contracts
Sources: Technology License Agreement (Acasti Pharma Inc.), Prepayment Agreement (Acasti Pharma Inc.), Technology License Agreement (Neptune Technologies & Bioressources Inc.)